Molina Healthcare, Inc. (MOH) is a publicly traded company in the Healthcare — Medical - Healthcare Plans industry listed on NYSE. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Molina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare programs, in addition to state health insurance marketplaces. Its operations are strategically segmented into four main divisions: Medicaid, Medicare, Marketplace, and a general "Other" category.
Is Molina Healthcare, Inc. stock overvalued or undervalued in 2026?
As of October 30, 2026, Molina Healthcare, Inc. (MOH) trades at $204.78 with no positive earnings over the last twelve months, according to Kaplio. No valuation verdict: it has no earnings to calculate a P/E from.
Kaplio overview: Molina Healthcare, Inc.
Market cap $11B · 52 weeks $123 – $243 (16 % below the high) · P/E no earnings · 2027 expected P/E 21.4× · Dividend none · Next earnings February 4, 2027 · expected EPS $0.56 · Closing price, Oct 30 · accounts published Oct 21.
- Valuation: EV/EBITDA 30.5× (no earnings).
- Business: ROIC 2 % (weak).
- Balance sheet: Net cash/EBITDA 0.3× (solid).
- Earnings: 4 of 8 (uneven).
What would it be worth at its usual multiples?
No valuation verdict: it has no earnings to calculate a P/E from.
What matters in pharma: 2 of 7 pass
- R&D / Revenue 0.0 %, fails.
- 5y EPS growth −4.0 %, fails.
- Gross margin 13.1 %, fails.
- FCF / Net Income −134.7 %, fails.
- ROIC 2.1 %, fails.
- Net debt / EBITDA −0.3×, passes.
- P/E vs own 10y history 19.4×, passes.
Against its peers (reference peers) — Molina Healthcare, Inc.: P/E —; EV/EBITDA 30.5×; ROIC 2.1 %; $10.7B. Oscar Health, Inc. (P/E 21.7×; EV/EBITDA 6.8×; ROIC 23.0 %; $7.9B), Centene Corp. (P/E 23.4×; EV/EBITDA 7.6×; ROIC 2.2 %; $33.9B), Humana Inc. (P/E 39.2×; EV/EBITDA 18.4×; ROIC 4.5 %; $49.8B).
Profitability
| Return on Equity | -1.17% |
| Return on Invested Capital | 2.08% |
| Return on Assets | -0.31% |
| Gross Margin | 8.06% |
| Operating Margin | 0.39% |
| Net Margin | -0.11% |
Financial Health
| Debt / Equity | 0.95 |
| Current Ratio | 1.69 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 4.26 |
Price Performance
| 1 month | +13.23% |
| 3 months | +4.68% |
| Year-to-date | +18.00% |
| 1 year | +33.79% |
| 3 years | -39.20% |
| 5 years | -31.27% |
| 10 years | +280.21% |
Related companies: UNH · CI · ELV · HUM · CNC · OSCR
Explore sector: Healthcare · Medical - Healthcare Plans
More sections of MOH: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks